Shannon Westin, MD, MPH, FACOG #LEAD2020
5:05
Missed the 2020 LEAD Conference? Catch up today with this conference overview from Dr. Shannon Westin.
Julie Vose, MD, MBA #LEAD2020
1:42
Conference overview highlights presented by Co-Chair, Dr. Julie Vose
Julie Brahmer, MD, MSc
5:42
Co-Chair, Julie Brahmer provides conference highlights from this year's virtual meeting
Nina Shah, MD #LEAD2020
4:17
LEAD 2020 Conference overview highlights presented by Co-Chair, Dr. Nina Shah
Bruna Pellini, MD #LEAD2020
3:38
Here Dr. Pellini highlight key takeaways from the 2020 LEAD Virtual Conference
5 Live - Major conference takeaways from experts in 5 minutes or less. Featuring new content from #ASH21 and #SABCS21
-
Sara Hurvitz, MD; University of California Los Angeles; 5Live #SABCS21
5:47
Key insights from the 2021 Annual Breast meeting in San Antonio
-
Larry Anderson, MD, PhD; UT Southwestern Medical Center; 5Live #ASH21
8:16
Key insights from the 2021 Annual Hematology meeting in Atlanta
-
Amitkumar Mehta, MD; University of Alabama at Birmingham O’Neal Comprehensive Cancer Center; 5Live #ASH21
8:55
Key insights from the 2021 Annual Hematology meeting in Atlanta
-
Nicole Lamanna, MD; Columbia University Irving Medical Center; 5Live #ASH21
11:27
Key insights from the 2021 Annual Hematology meeting in Atlanta
-
Javier Pinilla-Ibarz, MD, PhD; Moffit Cancer Center; 5Live #ASH21
12:43
Key insights from the 2021 Annual Hematology meeting in Atlanta
-
Naveen Pemmaraju, MD; The University of Texas MD Anderson Cancer Center; 5Live #ASH21
7:42
Key insights from the 2021 Annual Hematology meeting in Atlanta
-
Jennifer Woyach, MD; Ohio State; 5Live #ASH21
5:16
Key insights from the 2021 Annual Hematology meeting in Atlanta
-
Anand Tandra, MD; Franciscan Health Cancer Center; 5Live #ASH21
3:03
Key insights from the 2021 Annual Hematology meeting in Atlanta
-
Matthew Davids, MD, MMSc; Dana-Farber Cancer Institute; 5Live #ASH21
5:39
Key insights from the 2021 Annual Hematology meeting in Atlanta
Beyond the Congress: Key Conversations in Hematologic Malignancies from the Summer 2021 Annual Meetings
-
Ranjana Advani, MD; Stanford University #BtC_ASCO21
15:14
Dr. Ranjana Advani shares strategies for Integrating Recently Approved Therapies for B-cell NHL Into Practice.
-
Sagar Lonial, MD, FACP; Emory University #BtC_ASCO21
14:48
Dr. Sagar Lonial reviews Recently Presented Data of Clinical Trials and Standard of Care in Upfront Treatment for MM
-
John P. Leonard, MD; Weill Cornell Medicine #BtC_ASCO21
16:48
Dr. John Leonard discusses Recently Presented Data of Clinical Trials in Patients with NHL.
-
Selina Luger, MD, FRCPC; University of Pennsylvania #BtC_ASCO21
18:13
Dr. Selina Luger discusses Biomarkers and their Implications for Therapy in AML.
-
Maria-Victoria Mateos, MD, PhD; University of Salamanca #BtC_ASCO21
13:10
Dr. Maria-Victoria Mateos discusses Recently Presented Data of Clinical Trials and Standard of Care in Relapsed/Refractory MM
-
Jennifer R. Brown, MD, PhD; Dana-Farber Cancer Institute #BtC_ASCO21
15:33
Dr. Jennifer Brown reviews Recently Presented Data of Clinical Trials and Standard of Care in Relapsed/Refractory CLL.
-
Alison J. Moskowitz, MD; Memorial Sloan Kettering Cancer Center #BtC_ASCO21
16:28
Dr. Alison Moskowitz presents on Treatments for Upfront and Relapsed Hodgkin’s Lymphoma.
-
Nina Shah, MD; UCSF Health #BtC_ASCO21
15:53
Dr. Nina Shah reviews Considerations for the Community Provider in Using CAR T-Cell Therapies for MM
-
Nicole Lamanna, MD; Columbia University #BtC_ASCO21
16:56
Dr. Nicole Lamanna discusses Practical Issues in Treating CLL: Sequencing, Oral Adherence, Managing Adverse Events, and MRD Analysis.
